ALPHA WAVE GLOBAL LP
Q1 2025 Form 13-F

NEW YORK, NEW YORK
CIK 0001558858 · CRD 160894 · SEC-registered investment adviser
$224.5M Reported Value Total

ALPHA WAVE GLOBAL, LP reports 21 total accounts under management (AUM). There are 18 discretionary accounts valued at $6,093,879,985, and 3 non-discretionary accounts valued at $15,005,541,117.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary & Non-Discretionary
Private funds (Form ADV)
24 funds · $26.4B gross asset value
Private Equity Fund: $18.7B · Hedge Fund: $7.7B
Source: Form ADV filed 2026-08-31
Reported value
$224.5M
Quarter over quarter
-13.2%
Holdings
24
Top-10 concentration
93.5%

Key People

Form ADV owners & control persons
Matthew James Corey
CHIEF FINANCIAL OFFICER AND CO-CHIEF OPERATING OFFICER
Ryan Francis El Khoury
CO-FOUNDER AND PARTNER
Richard Matthew Gerson
FOUNDER, CHAIRMAN AND CHIEF INVESTMENT OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q1 2025 13F record

Q1 2025 13F filing summary

Q1 2025 Form 13F portfolio summary
Period of report March 31, 2025
Filed May 14, 2025
Form 13F-HR
Reported value $224.5M
Positions 24
Change in reported value +3.0%
New positions 5
Exited positions 3
Position turnover 29.6%
Top-10 concentration 93.5%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q2 2026 13F
Filed Aug 13, 2026
25 $6.2B
Q1 2026 13F
Filed May 14, 2026
20 $790.5M
Q4 2025 13F
Filed Feb 13, 2026
22 $815.7M
Q3 2025 13F
Filed Nov 13, 2025
28 $987.3M
Q2 2025 13F
Filed Aug 13, 2025
33 $928.2M
Q1 2025 13F
Filed May 14, 2025
24 $224.5M
Q4 2024 13F
Filed Feb 13, 2025
22 $217.9M
Q3 2024 13F
Filed Nov 13, 2024
20 $324.0M
Q2 2024 13F
Filed Aug 13, 2024
24 $305.3M
Q1 2024 13F
Filed May 14, 2024
26 $336.1M
Q4 2023 13F
Filed Feb 14, 2024
26 $207.3M
Q3 2023 13F
Filed Nov 13, 2023
26 $158.2M
Q2 2023 13F
Filed Aug 14, 2023
30 $152.7M
Q1 2023 13F
Filed May 15, 2023
45 $270.9M
Q4 2022 13F
Filed Feb 14, 2023
74 $547.6M
Q3 2022 13F
Filed Nov 14, 2022
112 $846.0M
Q2 2022 13F
Filed Aug 12, 2022
126 $972.5M
Q1 2022 13F
Filed May 13, 2022
124 $1.1B
Q4 2021 13F
Filed Feb 14, 2022
100 $900.2M
Q3 2021 13F
Filed Nov 12, 2021
132 $1.3B

33 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q1 2025

Largest Q1 2025 13F positions by reported value
# Holding Reported value % of portfolio
1 LENZ LENZ THERAPEUTICS INC $92.9M 41.37%
2 MTSR METSERA INC $64.9M 28.91%
3 WWD WOODWARD INC $12.7M 5.68%
4 RDNT RADNET INC $11.8M 5.24%
5 ANRO ALTO NEUROSCIENCE INC $8.0M 3.57%
6 CBZ CBIZ INC $6.7M 2.99%
7 ERII ENERGY RECOVERY INC $4.9M 2.18%
8 FLO FLOWERS FOODS INC $3.0M 1.32%
9 LNTH LANTHEUS HLDGS INC $2.6M 1.17%
10 CBL CBL & ASSOC PPTYS INC $2.3M 1.02%
11 NXE NEXGEN ENERGY LTD $2.2M 0.96%
12 ALIT ALIGHT INC $2.1M 0.93%
13 CRS CARPENTER TECHNOLOGY CORP $1.9M 0.85%
14 PAYO PAYONEER GLOBAL INC $1.6M 0.73%
15 AIV APARTMENT INVT & MGMT CO $1.6M 0.7%
16 DNN DENISON MINES CORP $1.5M 0.68%
17 PRCH PORCH GROUP INC $1.1M 0.5%
18 CLBR COLOMBIER ACQUISITION CORP I $738.9K 0.33%
19 AMLX AMYLYX PHARMACEUTICALS INC $663.1K 0.3%
20 CTEV CLARITEV CORPORATION $658.2K 0.29%

Values as reported on the Q1 2025 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings